<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Blair Dickey | Activity</title>
	<link>https://www.catswannabecats.com/members/koreanschool7/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/koreanschool7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Blair Dickey.</description>
	<lastBuildDate>Mon, 06 Jul 2026 08:03:58 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">0f36e941928abea63753210db2c7db7b</guid>
				<title>Blair Dickey posted an update: Purpose of review The treatment landscape for chronic [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/17678/</link>
				<pubDate>Tue, 03 Jun 2025 08:01:11 -0400</pubDate>

									<content:encoded><![CDATA[<p>Purpose of review The treatment landscape for chronic lymphocytic leukaemia (CLL) is rapidly evolving, with several targeted agents recently approved. These compounds have dramatically changed the natural history of the disease. <a href="https://www.selleckchem.com/products/pirtobrutinib-loxo-305.html" rel="nofollow ugc">BTK inhibitor</a> Recent findings However, with the array of effective therapies commercially available, the challenge is to&hellip;<span class="activity-read-more" id="activity-read-more-17678"><a href="https://www.catswannabecats.com/activity/p/17678/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">7d087b6ada2a2bc32953ace04f0c5c3e</guid>
				<title>Blair Dickey posted an update: In this article we present a biologically inspired model of [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/10068/</link>
				<pubDate>Sat, 31 May 2025 23:45:42 -0400</pubDate>

									<content:encoded><![CDATA[<p>In this article we present a biologically inspired model of activation of memory items in a sequence. Our model produces two types of sequences, corresponding to two different types of cerebral functions activation of regular or irregular sequences. The switch between the two types of activation occurs through the modulation of biological&hellip;<span class="activity-read-more" id="activity-read-more-10068"><a href="https://www.catswannabecats.com/activity/p/10068/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">66623b2a9a15ed7fd037dbbcbbfd9d13</guid>
				<title>Blair Dickey became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/9996/</link>
				<pubDate>Sat, 31 May 2025 23:32:46 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>